Skip to main content
Screener/Healthcare/Biotechnology

URGN — UroGen Pharma Ltd.

NASDAQ
$43.08+1.34 (+3.21%)
Mid CapUnder $50HealthcareFastest GrowingHigh BetaHigh ROE
$15.86
$50.81
$42.07
$43.18
EPS (TTM)$-3.20
P/E Ratio-7.74
Dividend Yield—
Market Cap$2.15B
Volume184K
Prev Close$41.74
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$37.8M-$26.4M$-0.5491.3%-69.7%
Q3 '25$27.5M-$33.3M$-0.6988.1%-121.3%
Q2 '25$24.2M-$49.9M$-1.0585.3%-206.2%
Q1 '25$20.3M-$43.8M$-0.9288.5%-216.5%
Q4 '24$24.6M-$37.5M$-0.8089.9%-152.7%
Q3 '24$25.2M-$23.7M$-0.5590.3%-93.9%
Q2 '24$21.8M-$33.4M$-0.9189.8%-152.9%
Q1 '24$18.8M-$32.3M$-0.9790.8%-171.9%
Get Your Daily Market Recap